Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD

Respiratory Care

Volumn 60, Issue 1, 2015, Pages 88-95

  Zanini, Andrea ^a,b   Aiello, Marina ^c   Adamo, Daniela ^a   Casale, Silvia ^a   Cherubino, Francesca ^a   Patrona, Sabrina Della ^a   Raimondi, Eleonora ^a   Zampogna, Elisabetta ^a   Chetta, Alfredo ^c   Spanevello, Antonio ^a,b  

^a IRCCS   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

COPD; EuroQol; Pulmonary rehabilitation; VAS

Indexed keywords

AGED; AIRWAY OBSTRUCTION; ARTICLE; BASELINE DYSPNEA INDEX; BLOOD GAS ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; EUROQOL GROUP 5 DIMENSION QUESTIONNAIRE; FATIGUE; FEMALE; FORCED VITAL CAPACITY; HUMAN; HYPERINFLATION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PULMONARY REHABILITATION; QUALITY OF LIFE; RESIDUAL VOLUME; RESPIRATORY TRACT DISEASE ASSESSMENT; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRANSITIONAL DYSPNEA INDEX; VISUAL ANALOG SCALE; VITAL CAPACITY; WALKING; AREA UNDER THE CURVE; COMPLICATION; DIRECTIVE COUNSELING; EXERCISE TEST; FORCED EXPIRATORY VOLUME; KINESIOTHERAPY; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX;

AGED; AREA UNDER CURVE; DIRECTIVE COUNSELING; DYSPNEA; EXERCISE TEST; EXERCISE THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; WALKING;

EID: 84935102164     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.03272     Document Type: Article

References (45)

1. Spruit MA, Singh SJ, Garvey C, ZuWallaek R, Niei L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188(8):e 13-e64.
2. Brooks R, Rabin R, De Charro F, eds. The measurement and validation of health status using EQ-5D: a European perspective; evidence from the EuroQol BIOMED Research Programme, 1st edition. Dordrecht, The Netherlands: Kluwer Academic Publishers, 2003.
3. Ståhl E, Lindberg A, Jansson SA, Rönmark E, Svensson K, Ander-sson F, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes 2005;3:56.
4. Rutten-van Mölken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest 2006; 130(4): 1117-1128.
5. Pickard AS, Yang Y, Lee TA. Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health Qual Life Outcomes 2011;9:26.
6. Wilke S, Janssen DJA, Wouters EFM, Schols JMGA, Franssen FME, Spruit MA. Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study. Health Qual Life Outcomes 2012; 10:98.
7. Menn P, Werber N, Holle R. Health-related quality of life in patients with severe COPD hospitalized for exacerbations: comparing EQ-5D, SF-12 and SGRQ. Health Qual Life Outcomes 2010;8:39.
8. Goossens LM, Nivens MC, Sachs P, Monz BU, Rutten-van Mölken MP. Is the EQ-5D responsive to recovery from a moderate COPD exacerbation? Respir Med 2011; 105(8): 1195-1202.
9. Solem CT, Sun SX, Sudharshan L, Macahilig C, Katyal M, Gao X. Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2013;8:641-652.
10. Ringbaek T, Brøndum E, Martinez G, Lange P. EuroQol in assessment of the effect of pulmonary rehabilitation COPD patients. Respir Med 2008; 102(11): 1563-1567.
11. Harper R, Brazier JE, Waterhouse JC, Walters SJ, Jones NM, Howard P. Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax 1997;52(10):879-887.
12. Zanini A, Chetta A, Gumiero F, Della Patrona S, Casale S, Zam-pogna E, et al. Six-minute walking distance improvement after pulmonary rehabilitation is associated with baseline lung function in clinically complex COPD patients: a retrospective study. Biomed Res Int 2013;2013:483162.
13. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategies for the diagnosis, management and prevention of chronic pulmonary disease. Updated 2014. http://www.goldcopd.org/ guidelines-global-strategy-for-diagnosis-management.html. Accessed September 18, 2014.
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-383.
15. Hill K, Bansal V, Brooks D, Goldstein RS. Repeat pulmonary rehabilitation programs confer similar increases in functional exercise capacity to initial programs. J Cardiopulm Rehabil Prev 2008;28(6): 410-414.
16. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
17. Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC. Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:41-52.
18. Mahler DA, Guyatt GH, Jones PW. Clinical measurements of dyspnoea. In: Mahler, DA. Dyspnoea. New York: Marcel Dekker; 1998.
19. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166(1): 111-117.
20. Fuchs-Climent D, Le Gallais D, Varray A, Desplan J, Cadopi M, Préfaut C. Quality of life and exercise tolerance in chronic obstructive pulmonary disease: effects of a short and intensive inpatient rehabilitation program. Am J Phys Med Rehabil 1999;78(4):330-335.
21. Clini E, Foglio K, Bianchi L, Porta R, Vitacca M, Ambrosino N. In-hospital short-term training program for patients with chronic airway obstruction. Chest 2001;120(5): 1500-1505.
22. Cilione C, Lorenzi C, Dell Orso D, Garuti G, Rossi G, Totaro L, Clini E. Predictors of change in exercise capacity after comprehensive COPD inpatient rehabilitation. Med Sci Monit 2002;8(11): CR740-745.
23. Carone M, Patessio A, Ambrosino N, Baiardi P, Balbi B, Balzano G, et al. Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): the Maugeri study. Respir Med 2007; 101 (12):2447-2453.
24. Zainuldin MR, Knoke D, Mackey MG, Luxton N, Alison JA. Prescribing cycle training intensity from the six-minute walk test for patients with COPD. BMC Pulm Med 2007;7:9.
25. Make B. How can we assess outcomes of clinical trials: the MCID approach. COPD 2007;4(3): 191-194.
26. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39(4):561-577.
27. Witek TJ Jr, Mahler DA. Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J 2003;21 (2):267-272.
28. Witek TJ Jr., Mahler DA. Meaningful effect size and patterns of response of the transition dyspnea index. J Clin Epidemiol 2003; 56(3):248-255.
29. de Torres JP, Casanova C, Hernández C, Abreu J, Aguirre-Jaime A, Celli BR. Gender and COPD in patients attending a pulmonary clinic. Chest 2005; 128(4):2012-2016.
30. Naberan K, Azpeitia A, Cantoni J, Miravitlles M. Impairment of quality of life in women with chronic obstructive pulmonary disease. Respir Med 2012; 106(3):367-373.
31. Foy CG, Rejeski WJ, Berry MJ, Zaccaro D, Woodard CM. Gender moderates the effects of exercise therapy on health-related quality of life among COPD patients. Chest 2001; 119(1):70-76.
32. Robles PG, Brooks D, Goldstein R, Salbach N, Mathur S. Gender-associated differences in pulmonary rehabilitation outcomes in people with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev 2014;34(2):87-97.
33. Barr JT, Schumacher GE, Freeman S, LeMoine M, Bakst AW, Jones PW. American translation, modification, and validation of the St. George's Respiratory Questionnaire. Clin Ther 2000;22(9):1121-1145.
34. Al MJ, Koopmanschap MA, van Enckevort PJ, Geertsma A, van der Bij W, de Boer WJ, TenVergert EM. Cost-effectiveness of lung transplantation in the Netherlands. Chest 1998; 113(1): 124-130.
35. Monninkhof E, van der Valk P, Schermer T, van der Palen J, van Herwaarden C, Zielhuis G. Economic evaluation of a comprehensive self-management programme in patients with moderate to severe chronic obstructive pulmonary disease. Chron Respir Dis 2004; 1(1): 7-16.
36. Covelli H, Bhattacharya S, Cassino C, Conoscenti C, Kesten S. Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary disease. Pharmacotherapy 2005;25(12): 1708-1718.
37. Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005; 14(6): 1523-1532.
38. Pickard AS, Neary MP, Cella D. Estimation of minimally important difference in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 2007;5:70.
39. MacIntyre NR. Mechanisms of functional loss in patients with chronic lung disease. Respir Care 2008 Sep;53(9):1177-1184.
40. Foglio K, Bianchi L, Ambrosino N. Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2-year controlled study. Chest 2001; 119(6): 1696-1704.
41. Romagnoli M, Dell'Orso D, Lorenzi C, Crisafulli E, Costi S, Lugli D, Clini EM. Repeated pulmonary rehabilitation in severe and disabled COPD patients. Respiration 2006;73(6):769-776.
42. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008;61 (2): 102-109.
43. Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med 2014;189(3):250-255.
44. Kon SS, Dilaver D, Mittal M, Nolan CM, Clark AL, Canavan JL, et al. The Clinical COPD Questionnaire: response to pulmonary rehabilitation and minimal clinically important difference. Thorax. 2014; 69(9):793-820.
45. Jones SE, Kon SS, Canavan JL, Patel MS, Clark AL, Nolan CM, et al. The five-repetition sit-to-stand test as a functional outcome measure in COPD. Thorax 2013;68(11): 1015-1020.